RBR-3cjbq5
Not Yet Recruiting
N/A
Randomized comparative single blinded clinical trial on the effectiveness and safety of microneedling in the treatment of androgenetic alopecia.
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Androgenetic alopecia
- Sponsor
- Hospital São Paulo
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Signature of Written Informed Consent Form and Authorization for Photographs Term prior to any study procedure; men aged between 18 and 60 years, in good health; Clinical diagnosis of moderate male androgenet alopecia (Stage IIIa\-IV of the Norwood\-Hamilton Scale) with disease onset time less than 10 years; accordance with the conditions of the study, ability to understand and strictly follow the therapeutic guidelines received and availability to attend periodic evaluations.
Exclusion Criteria
- •Men who do not agree with the conditions of the study or who are unable to understand and strictly follow the therapeutic guidelines received, are not available to attend periodic evaluations or refuse to sign the Written Informed Consent Form and Authorization for Photographs Term; patients suffering from other alopecias, including telogen effluvium; patients with mild disease (stages I and II) or severe disease (stages V to VII of the Norwood\-Hamilton Scale); patients who have androgenetic alopecia for more than 10 years; previous use of finasteride or dutasteride in the last 6 months; patients with a current or previous history of malignant or pre\-malignant tumors of the scalp; patients that suffer from allergic contact dermatitis to propylene glycol (minoxidil vehicle), minoxidil, tattoo ink, topical or local anesthetic; patients that have dermatoses that may worsen due to the procedure and interfere with the evaluation, such as psoriasis, vitiligo; patients receiving chemotherapy, radiation therapy, corticosteroids or other immunosuppressants.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 2
Ayurvedic intervention in severe grade Pre menstrual syndromeCTRI/2024/04/066481Shri Dhanwantry Ayurvedic College and Hospital Sector 46 B Chandigarh
Not Yet Recruiting
Phase 2
Clinical Trial of Herbal Preparation (Laxoherb Kid SyrupR) for Constipation in ChildreHealth Condition 1: K929- Disease of digestive system, unspecifiedCTRI/2024/08/072577Jupiter Pharmaceuticals Limited
Active, Not Recruiting
N/A
concentration of sevoflurane associated to remifentanil required for insertion of the SupremeLaryngeal Mask versus Pro-Seal Laryngeal MaskPatients requiring general anesthesia in whom the control of the airwayis usually done with a supraglottic device.MedDRA version: 16.1Level: LLTClassification code 10018061Term: General anesthesiaSystem Organ Class: 100000004865Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]EUCTR2012-004163-50-ESFundación para la Investigación Biomédica del Hospital
Active, Not Recruiting
Phase 3
A Clinical study for Ayurvedic management of Migraine without AuraHealth Condition 1: G437- Chronic migraine without auraCTRI/2020/06/025607Dr Divya Virupaksha
Not Yet Recruiting
Phase 2
Effects of umbilical cord derived mesenchymal stem cells injection in the treatment of children with cerebral palsySpastic Cerebral Palsy.Spastic quadriplegic cerebral palsyG80.0IRCT20110628006907N18ROYAN stem cell technology Co150